Breast Cancer

The evolving landscape of breast cancer treatment emphasizes the pivotal role of ESR1 inhibitors in combating endocrine resistance. Targeting mutations in ER-positive breast cancer, key inhibitors, like camizestrant and elacestrant, show promising results in extending progression-free survival. Precision diagnostics and strategic treatments reveal the transformative potential of therapies in patient outcomes. Understand insights into crucial […]

Metastatic breast cancer treatments face new complexities with the advent of ESR1 mutations, especially in hormone receptor-positive, HER2-negative cases. ESR1 mutations drive endocrine resistance and tumor growth, posing challenges after CDK4/6 inhibitor use. With emerging therapies like selective estrogen receptor degraders and advancing diagnostic methods, managing ESR1 mutations offers hope for improved patient outcomes. A […]

Breast cancer is one of the most prevalent cancers, impacting millions of lives across the globe. Recognizing its symptoms, understanding the risk factors, and exploring available treatment options are crucial steps toward early detection and improved outcomes. Common signs include lumps, changes in breast appearance, and unusual discharge. With increased awareness, regular screenings, and proactive […]